Observational study of pimecrolimus 1% cream for prevention of transcutaneous sensitization in children with atopic dermatitis during their first year of life

INTRODUCTION: Epidermal barrier dysfunction in children with atopic dermatitis can cause transcutaneous sensitization to allergens and allergic diseases. We evaluated the effectiveness of an early-intervention algorithm for atopic dermatitis treatment, utilizing pimecrolimus for long-term maintenanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Murashkin, Nikolay N., Namazova-Baranova, Leyla S., Makarova, Svetlana G., Ivanov, Roman A., Grigorev, Stepan G., Fedorov, Dmitri V., Ambarchian, Eduard T., Epishev, Roman V., Materikin, Alexander I., Opryatin, Leonid A., Savelova, Alena A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167287/
https://www.ncbi.nlm.nih.gov/pubmed/37181420
http://dx.doi.org/10.3389/fped.2023.1102354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167287/
https://www.ncbi.nlm.nih.gov/pubmed/37181420
http://dx.doi.org/10.3389/fped.2023.1102354

Ejemplares similares